Shane Roller

962 total citations
24 papers, 359 citations indexed

About

Shane Roller is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Shane Roller has authored 24 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in Shane Roller's work include Neuropeptides and Animal Physiology (8 papers), Migraine and Headache Studies (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Shane Roller is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Migraine and Headache Studies (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Shane Roller collaborates with scholars based in United States, United Kingdom and Poland. Shane Roller's co-authors include Christine M. Dieckhaus, Timothy L. Macdonald, Charles D. Thompson, Webster L. Santos, R. Duane Sofia, Chari D. Smith, Scott D. Mosser, Joseph P. Vacca, Huiqiang Zhou and Anthony L. Handlon and has published in prestigious journals such as Cancer Research, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

Shane Roller

23 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shane Roller United States	12	143	92	66	65	62	24	359
Jurema Schmidt Germany	15	222 1.6×	83 0.9×	28 0.4×	49 0.8×	85 1.4×	28	499
Joan D. Ellis United States	14	129 0.9×	60 0.7×	62 0.9×	31 0.5×	30 0.5×	19	483
Roberto Nuti Italy	11	304 2.1×	93 1.0×	33 0.5×	38 0.6×	28 0.5×	16	628
Takanobu Kuroita Japan	12	235 1.6×	121 1.3×	49 0.7×	41 0.6×	70 1.1×	27	530
Dwight D. Stiff United States	13	158 1.1×	31 0.3×	23 0.3×	121 1.9×	21 0.3×	18	444
E. Pianezzola Italy	14	118 0.8×	28 0.3×	21 0.3×	70 1.1×	78 1.3×	32	567
Thomas Lauterbach Germany	11	120 0.8×	68 0.7×	60 0.9×	100 1.5×	29 0.5×	16	423
Yi‐Hui Peng Taiwan	9	273 1.9×	99 1.1×	71 1.1×	18 0.3×	13 0.2×	12	503
Paul Moench United States	8	73 0.5×	24 0.3×	61 0.9×	16 0.2×	38 0.6×	12	322
Bahman M. Sadeghpour Italy	12	177 1.2×	160 1.7×	36 0.5×	77 1.2×	34 0.5×	18	917

Countries citing papers authored by Shane Roller

Since Specialization

Citations

This map shows the geographic impact of Shane Roller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Roller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Roller more than expected).

Fields of papers citing papers by Shane Roller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane Roller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Roller. The network helps show where Shane Roller may publish in the future.

Co-authorship network of co-authors of Shane Roller

This figure shows the co-authorship network connecting the top 25 collaborators of Shane Roller. A scholar is included among the top collaborators of Shane Roller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane Roller. Shane Roller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maese, Luke, Mignon L. Loh, Mi Rim Choi, et al.. (2024). Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children’s Oncology Group AALL1931 study. Blood Advances. 9(1). 66–77.

Hauptschein, Robert, Simon A. Woodcock, Andrew Belfield, et al.. (2022). Abstract 2677: JZP815, a potent and selective pan-RAF inhibitor, demonstrates efficacy in RAF and RAS mutant tumor pre-clinical models. Cancer Research. 82(12_Supplement). 2677–2677. 1 indexed citations

Romano, Joseph, Marc M. Baum, Charles Dobard, et al.. (2021). Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting. AIDS Research and Human Retroviruses. 37(6). 409–420. 19 indexed citations

Roller, Shane, Rachna Jain, Yan Wang, et al.. (2021). A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs. Microbiology Spectrum. 9(1). e0033921–e0033921. 5 indexed citations

Huang, David, Vân Nguyên-Trân, Sean B. Joseph, et al.. (2020). Engineering of a Potent, Long-Acting NPY2R Agonist for Combination with a GLP-1R Agonist as a Multi-Hormonal Treatment for Obesity. Journal of Medicinal Chemistry. 63(17). 9660–9671. 19 indexed citations

Roller, Shane, Mark Paulik, J. Douglas Way, et al.. (2018). Continuous Subcutaneous Delivery of a Glucagon Analog, ICA6150349, to Rats and Nonhuman Primates Demonstrates Safety and Tolerability in a 14-Day Toxicity Study. Diabetes. 67(Supplement_1). 1 indexed citations

Sparks, Steven M., Paul K. Spearing, David J. Cowan, et al.. (2017). Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration. Bioorganic & Medicinal Chemistry Letters. 27(20). 4673–4677. 6 indexed citations

Sparks, Steven M., Christopher Aquino, Jon L. Collins, et al.. (2017). Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist. Bioorganic & Medicinal Chemistry Letters. 27(5). 1278–1283. 22 indexed citations

Wood, Michael R., Rodney A. Bednar, John F. Fay, et al.. (2010). Novel CGRP receptor antagonists from central amide replacements causing a reversal of preferred chirality. Bioorganic & Medicinal Chemistry Letters. 20(22). 6827–6830. 9 indexed citations

10.

Paone, Daniel V., Diem N. Nguyen, Anthony W. Shaw, et al.. (2010). Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: Discovery of MK-2918. Bioorganic & Medicinal Chemistry Letters. 21(9). 2683–2686. 14 indexed citations

11.

Bell, Ian M., Steven N. Gallicchio, Michael R. Wood, et al.. (2010). Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist. ACS Medicinal Chemistry Letters. 1(1). 24–29. 46 indexed citations

12.

Roller, Shane, et al.. (2009). Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences. Xenobiotica. 39(1). 33–45. 15 indexed citations

13.

Burgey, Christopher S., James Z. Deng, Scott D. Mosser, et al.. (2009). Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: Development of novel spiropiperidines. Bioorganic & Medicinal Chemistry Letters. 19(22). 6368–6372. 11 indexed citations

14.

Wood, Michael R., Craig A. Stump, Ian M. Bell, et al.. (2009). Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility. Bioorganic & Medicinal Chemistry Letters. 19(19). 5787–5790. 10 indexed citations

15.

Trzupek, John D., Shane Roller, Heather L. Handl, et al.. (2004). A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. Bioorganic & Medicinal Chemistry. 12(23). 6221–6236. 18 indexed citations

16.

Dieckhaus, Christine M., Charles D. Thompson, Shane Roller, & Timothy L. Macdonald. (2002). Mechanisms of idiosyncratic drug reactions: the case of felbamate. Chemico-Biological Interactions. 142(1-2). 99–117. 57 indexed citations

17.

Roller, Shane, Christine M. Dieckhaus, Webster L. Santos, R. Duane Sofia, & Timothy L. Macdonald. (2002). Interaction between Human Serum Albumin and the Felbamate Metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-Phenylpropenal. Chemical Research in Toxicology. 15(6). 815–824. 22 indexed citations

18.

Jennings, S. A., Shane Roller, Natalie Brooks, et al.. (2001). EFFICIENT SYNTHESIS OF (±)-seco-CYCLOPROPANEINDOLINE ANALOGS OF CC-1065. Heterocyclic Communications. 7(1). 7–16. 3 indexed citations

19.

Carnahan, Michael A., et al.. (2000). Probing the Active Site of Yeast Alcohol Dehydrogenase through Microscale Yeast-Mediated Reductions of Acetophenone and Acetylpyridines. A Collaborative and Research-Based Advanced Bioorganic Chemistry Laboratory Project. Journal of Chemical Education. 77(3). 363–363. 4 indexed citations

20.

Roller, Shane, H. Lode, Ingeborg Stelzer, et al.. (1992). Pharmacokinetics of loracarbef and interaction with acetylcysteine. European Journal of Clinical Microbiology & Infectious Diseases. 11(9). 851–855. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact